HCPCS Level II code L8658 denotes an interphalangeal joint spacer, silicone or equal, billed per device. This implantable orthopedic device is used in surgical management of interphalangeal joint disease—commonly for pain relief, stabilization, or reconstruction in finger or toe joints—and is relevant to surgeons, hospital billing teams, and payers due to device-specific coding and coverage considerations. Nationally, accurate use of L8658 affects device tracking, claims adjudication, and durable medical equipment or implant reporting.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what the code represents, the clinical context for use, typical sites of service where the device is implanted, and which payers commonly adjudicate these claims. The publication summarizes billing considerations, common modifiers (listed separately), and contextual benchmarks where available. It also highlights areas where policy clarification or preauthorization practices commonly arise for implantable joint spacers.

This summary is intended for a national audience of clinicians, coding professionals, and policy analysts seeking a clear reference on the clinical and billing identity of HCPCS Level II code L8658. Data not available in the input is noted where applicable.